No BS Just Facts logo
No BS Just Facts
It might be boring, but it's just the facts.

← All stories · business

CNBC

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

Wednesday, November 18, 2026


Hims & Hers began offering compounded forms of sermorelin, glutathione, NAD+, vitamin B-12, and L-carnitine through its telehealth platform. None of these compounds are approved by the FDA for the marketed purposes. The company acknowledged in its announcement that additional research is needed to establish efficacy.

Original reporting:

Next story

JPMorgan Adds Dallas Hub for Private Bank Unit Catering to Funds→